Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-23-012415

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading avtx-20230420.htm…